Noroclav 50 mg Chewable Flavoured Tablets for Cats and Dogs

País: Reino Unido

Língua: inglês

Origem: VMD (Veterinary Medicines Directorate)

Ingredientes ativos:

Amoxicillin, Clavulanic Acid

Disponível em:

Norbrook Laboratories Limited

Código ATC:

QJ01CR02

DCI (Denominação Comum Internacional):

Amoxicillin, Clavulanic Acid

Forma farmacêutica:

Chewable tablet

Tipo de prescrição:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapêutico:

Cats, Dogs

Área terapêutica:

Antimicrobial

Status de autorização:

Expired

Data de autorização:

2012-06-13

Características técnicas

Revised: August 2017
AN: 00726/2016
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Noroclav 50 mg Chewable Flavoured Tablets for Cats and
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Active ingredients:
Amoxicillin 40.00 mg
(as Amoxicillin Trihydrate)
Clavulanic acid 10.00 mg
(as Potassium Clavulanate)
Excipients:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable Tablet.
Pale brown circular tablet with a score line and embossed with
‘50’ on opposing faces.
The tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of the following infections caused by beta-lactamase
producing strains of
bacteria sensitive to amoxicillin in combination with clavulanic acid:
Skin infections (including superficial and deep pyodermas) caused by
Staphylococcus
spp.
Urinary tract infections caused by Staphylococcus spp or Escherichia
coli.
Respiratory tract infections caused by Staphylococcus spp.
Enteritis caused by Escherichia coli.
Dental infections (e.g. gingivitis)
It is recommended to carry out suitable tests for sensitivity when
initiating the treatment.
The treatment should only proceed if sensitivity is proven to the
combination.
4.3 CONTRAINDICATIONS
The product should not be given to rabbits, hamsters, guinea pigs or
gerbils.
Revised: August 2017
AN: 00726/2016
Page 2 of 7
Do not use in animals with known hypersensitivity to penicillin, other
beta-lactams or
any of the excipients.Do not use in animals with serious dysfunction
of the kidneys
accompanied by anuria or oliguria.
Do not use where resistance to this combination is known to occur.
Do not administer to horses and ruminating animals.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Whenever possible, the product should only be used based on
susceptibility testing.
Use of the product